Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    NC-100692
Show Display Options
Rank Status Study
1 Terminated
Has Results
Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction
Conditions: Diabetes Mellitus;   Heart Failure
Intervention: Drug: Tc99m-Maraciclatide
2 Active, not recruiting Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis
Conditions: Hypertrophic Cardiomyopathy;   Acute Coronary Syndrome
Intervention: Radiation: 99mTc-NC100692
3 Unknown  The Role of the Novel 99mTc-NC100692 Tracer in Patients at High Risk or Known Breast Cancer
Conditions: Breast Cancer;   Tumor Angiogenesis
4 Completed Detection of Aggressive Breast Tumors Using Tc-99m-NC100692
Condition: Breast Cancer

Indicates status has not been verified in more than two years